Cladosporium, IgE, Serum
Use
This test is used for establishing a diagnosis of an allergy to Cladosporium. It helps in defining the allergen responsible for eliciting signs and symptoms and identifying allergens responsible for allergic response and/or anaphylactic episodes. It is also used to confirm sensitization prior to beginning immunotherapy and to investigate the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.
Special Instructions
Not provided.
Limitations
Testing for IgE antibodies is not useful in patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or in cases where medical management does not rely on identifying allergen specificity. Some individuals may have measurable levels of IgE antibodies despite clinically insignificant sensitivity, and false-positive results may occur in patients with elevated serum IgE due to nonspecific binding.
FDA ApprovedNew York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
IgE
Protein
LOINC Codes
- 53760-5 - Cladosporium IgE Qn
- 53760-5 - Cladosporium IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL for every 5 allergens requested
Minimum Volume
0.3 mL for 1 allergen
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
None specified for gross hemolysis or lipemia
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |